like to stress our key observational finding, that supraventricular arrhythmias were identified in one seventh of the patients with positive AMA-M2 test results. The possible association between AMA-M2 and atrial myocardial involvement that was suggested in the present study should be verified in the future, using a prospective and multi-center study design, as they suggested in their final key statement. Although we have discussed a possible mechanism of AMA-M2-asociated myocardial involvement and supraventricular arrhythmias, it does not go beyond speculation at the present time. Based on their interest and kind response to our investigation (1), we hope that the present study will arouse the interest of many physicians, leading them to maintain continuous observation and to accumulate cases of AMA-M2-positive patients in routine clinical practice. This helps to clarify the mechanism of myocardial involvement and supraventricular arrhythmias. 
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